Hemaglobin A1c
Showing 1 - 25 of >10,000
A Study of Glycemic Control in Left Ventricular Assist
Not yet recruiting
- Type 2 Diabetes Mellitus
- +2 more
- Freestyle Libre 3 Continuous Glucose Monitor (CGM)
-
Rochester, MinnesotaMayo Clinic in Rochester
Jun 28, 2023
Electronic Triggers: Messaging After A1C EHR Alert
Active, not recruiting
- Hemoglobins
- Diagnostic Tests
- MyChart message
-
New York, New YorkNYU Langone Health
Jan 26, 2023
Diabetes, Type 2, Sleep Trial in East Lansing (Sleep education, Diet only)
Completed
- Diabetes Mellitus, Type 2
- Sleep
- Sleep education
- Diet only
-
East Lansing, MichiganMichigan State University
Dec 2, 2022
Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders (Including Diabetes) Trial in Canada (Support-t)
Not yet recruiting
- Diabetes Mellitus
- +6 more
- Support-t
-
Gatineau, Canada
- +3 more
Jun 16, 2023
Healthy Subjects Trial in SEoul (C1K, Placebo)
Recruiting
- Healthy Subjects
- C1K
- Placebo
-
SEoul, Korea, Republic ofSeoul National University Clinical Trial Center
Aug 3, 2023
Diabetes, Type 1, Type1diabetes, Insulin Dependent Diabetes Trial in Montreal (Active arm, Control arm)
Active, not recruiting
- Diabetes Mellitus, Type 1
- +2 more
- Active arm
- Control arm
-
Montreal, Quebec, Canada
- +1 more
Nov 25, 2021
CYP1A2, ABCB1, CYP2C9 and Plasma Concentration of Agomelatine in
Not yet recruiting
- Polymorphism, Genetic
- +5 more
- (no location specified)
Nov 3, 2023
Diabetes, Type 2 Trial (LIBERATE)
Not yet recruiting
- Diabetes Mellitus, Type 2
- LIBERATE
- (no location specified)
Aug 11, 2022
Hemoglobin A1c and Acute Kindey Injury After Coronary Artery
Completed
- Acute Kidney Injury
- increase in serum creatinine
-
Cairo, EgyptAin-Shams University
May 22, 2022
Recurrent High Grade Glioma Trial (MVR-C5252)
Not yet recruiting
- Recurrent High Grade Glioma
- MVR-C5252
- (no location specified)
Nov 6, 2023
Healthy Trial in Seoul (C1K 150mg, C1K 300mg, Placebo with the same volume of C1K 300mg)
Recruiting
- Healthy
- C1K 150mg
- +8 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jan 25, 2023
Parkinson Disease Trial (1 : S-C1-C2, 2 : S-C2-C1, 3 : C1 - S - C2)
Recruiting
- Parkinson Disease
- 1 : S-C1-C2
- +5 more
-
Toulouse, FranceUh Toulouse
Nov 3, 2022
Solid Tumor Trial in Kashiwa-shi, Matsuyama-shi, Koto-Ku (M1-c6v1)
Not yet recruiting
- Solid Tumor
- M1-c6v1
-
Kashiwa-shi, Chiba, Japan
- +2 more
Sep 19, 2023
Point of Care Device to Measure HbA1c
Not yet recruiting
- Pregnant
- Postpartum
- Point of care device to measure HbA1c
- (no location specified)
Feb 10, 2023
Diabetes, Type 2 Trial in Bogotá (Point of Care - Glycated Hemoglobin (A1c), Oral Glucose Tolerance Test)
Recruiting
- Diabetes Mellitus, Type 2
- Point of Care - Glycated Hemoglobin (A1c)
- Oral Glucose Tolerance Test
-
Bogotá, ColombiaMaria Granados
Jul 5, 2022
Healthy Volunteers Trial in Groningen (DC-806, [14C]-DC-806)
Recruiting
- Healthy Volunteers
-
Groningen, NetherlandsICON Phase 1 Clinic
Sep 13, 2023
ALS Trial ([11C]CPPC PET ligand)
Not yet recruiting
- ALS
- [11C]CPPC PET ligand
- (no location specified)
Jan 9, 2023
Glucose Intolerance, Glucose Metabolism Disorders (Including Diabetes) Trial in West Lafayette (Almond, Control)
Recruiting
- Glucose Intolerance
- Glucose Metabolism Disorders (Including Diabetes Mellitus)
- Almond
- Control
-
West Lafayette, IndianaPurdue Univeristy
Apr 18, 2022
Healthy Trial in Madison ([14C]-LY3871801)
Not yet recruiting
- Healthy
-
Madison, WisconsinCovance Clinical Research Unit
Sep 15, 2023
Healthy Trial in Madison ([¹4C]-LOXO-783, LOXO-783)
Not yet recruiting
- Healthy
-
Madison, WisconsinFortrea Clinical Research
Oct 23, 2023
Optimal A1c Control in Post Liver or Combined Liver and Kidney
Withdrawn
- Diabetes
- +2 more
- hemoglobin A1c
-
Dallas, TexasMethodist Health System
Sep 10, 2021
HIV Vaccine, HIV-1-infection Trial in Chapel Hill, Durham (C62, C1C62, Placebo)
Recruiting
- HIV Vaccine
- HIV-1-infection
- C62
- +4 more
-
Chapel Hill, North Carolina
- +1 more
Oct 27, 2022
Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))
Not yet recruiting
- Muscarinic Receptor Occupancy
- Scopolamine
- [11C]EMO ([11C]LSN3172176)
-
New Haven, ConnecticutYale University
Aug 31, 2023
Chronic Pain, Knee Pain Chronic, Post Operative Pain Trial in Toronto (Vitamin C, Placebo)
Not yet recruiting
- Chronic Pain
- +2 more
- Vitamin C
- Placebo
-
Toronto, Ontario, Canada
- +2 more
Nov 7, 2023